There are 2789 resources available
1037O - MASTERKEY-265: A phase III, randomized, placebo (Pbo)-controlled study of talimogene laherparepvec (T) plus pembrolizumab (P) for unresectable stage IIIB–IVM1c melanoma (MEL)
Presenter: Helen Gogas
Session: Proffered Paper session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
1O - Harnessing innate immunity in cancer therapies: The example of natural killer cell engagers
Presenter: Eric Vivier
Session: Proffered Paper session - Basic science
Resources:
Abstract
Slides
Webcast
2O - Penpulimab, an IgG1 anti-PD-1 antibody with Fc-engineering to eliminate effector functions and with unique epitope and binding properties
Presenter: Baiyong Li
Session: Proffered Paper session - Basic science
Resources:
Abstract
Slides
Webcast
3O - Patient-derived micro-organospheres (MOS) recapitulate tumor microenvironment and heterogeneity for precision oncology
Presenter: Shengli Ding
Session: Proffered Paper session - Basic science
Resources:
Abstract
Slides
Webcast
1800O - Multi-omic characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
Presenter: Álvaro Quintanal-Villalonga
Session: Proffered Paper session - Basic science
Resources:
Abstract
Slides
Webcast
Introduction by the chair
Presenter: Fabrice André
Session: All patients with newly diagnosed mBC should receive a comprehensive profiling using multigene sequencing
Resources:
Slides
Webcast
Yes
Presenter: Cristina Saura Manich
Session: All patients with newly diagnosed mBC should receive a comprehensive profiling using multigene sequencing
Resources:
Slides
Webcast
No
Presenter: Evandro de Azambuja
Session: All patients with newly diagnosed mBC should receive a comprehensive profiling using multigene sequencing
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Fabrice André
Session: All patients with newly diagnosed mBC should receive a comprehensive profiling using multigene sequencing
Resources:
Slides
Webcast
Q&A
Presenter: Fabrice André
Session: All patients with newly diagnosed mBC should receive a comprehensive profiling using multigene sequencing
Resources:
Slides
Webcast